Thus, this study aims to investigate WT1 gene expression profiles in AML patients at diagnosis, post-induction, and relapse stages using RT-qPCR and RNA-Seq to assess its role in disease progression and evaluate its potential as a diagnostic and prognostic biomarker. The gene discussed is WT1; the disease is acute myeloid leukemia.